{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:22:39Z","timestamp":1761718959190,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Mutations in <jats:italic>RAB39B<\/jats:italic> at Xq28 causes a rare form of X-linked intellectual disability (ID) and Parkinson\u2019s disease. Neurofibromatosis type 1 (NF1) is caused by heterozygous mutations in <jats:italic>NF1<\/jats:italic> occurring de novo in about 50% of cases, usually due to paternal gonadal mutations. This case report describes clinical and genetic findings in a boy with the occurrence of two distinct causative mutations in <jats:italic>NF1<\/jats:italic> and <jats:italic>RAB39B<\/jats:italic> explaining the observed phenotype.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Here we report a 7-year-old boy with multiple caf\u00e9-au-lait macules (CALMs) and freckling, severe macrocephaly, peculiar facial gestalt, severe ID with absent speech, epilepsy, autistic traits, self-harming, and aggressiveness. Proband is an only child born to a father aged 47. Parents did not present signs of NF1, while a maternal uncle showed severe ID, epilepsy, and tremors.By RNA analysis of <jats:italic>NF1<\/jats:italic>, we identified a de novo splicing variant (NM_000267.3:c.6579+2T&gt;C) in proband, which explained NF1 clinical features but not the severe ID, behavioral problems, and aggressiveness. Family history suggested an X-linked condition and massively parallel sequencing of X-exome identified a novel <jats:italic>RAB39B<\/jats:italic> mutation (NM_171998.2:c.436_447del) in proband, his mother, and affected maternal uncle, subsequently validated by Sanger sequencing in these and other family members.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The case presented here highlights how concurrent genetic defects should be considered in NF1 patients when <jats:italic>NF1<\/jats:italic> mutations cannot reasonably explain all the observed clinical features.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01911-0","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T09:02:49Z","timestamp":1598950969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Claudia","family":"Santoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalaura","family":"Torella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"del Vecchio Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Onore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-125X","authenticated-orcid":false,"given":"Giulio","family":"Piluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"2","key":"1911_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajhg.2010.01.011","volume":"86","author":"M Giannandrea","year":"2010","unstructured":"Giannandrea M, Bianchi V, Mignogna ML, Sirri A, Carrabino S, D'Elia E, et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet. 2010;86(2):185\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2010.01.011.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1911_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","volume":"95","author":"GR Wilson","year":"2014","unstructured":"Wilson GR, Sim JC, McLean C, Giannandrea M, Galea CA, Riseley JR, et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology. Am J Hum Genet. 2014;95(6):729\u201335. https:\/\/doi.org\/10.1016\/j.ajhg.2014.10.015.","journal-title":"Am J Hum Genet"},{"key":"1911_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13229-017-0175-3","volume":"8","author":"M Woodbury-Smith","year":"2017","unstructured":"Woodbury-Smith M, Deneault E, Yuen RKC, Walker S, Zarrei M, Pellecchia G, et al. Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly. Mol Autism. 2017;8:59. https:\/\/doi.org\/10.1186\/s13229-017-0175-3.","journal-title":"Mol Autism"},{"key":"1911_CR4","doi-asserted-by":"publisher","unstructured":"Gao Y, Wilson GR, Stephenson SEM, Oulad-Abdelghani M, Charlet-Berguerand N, Bozaoglu K, et al. Distribution of Parkinson's disease associated RAB39B in mouse brain tissue. Mol Brain. 2020;13(1):\u201352. https:\/\/doi.org\/10.1186\/s13041-020-00584-7.","DOI":"10.1186\/s13041-020-00584-7"},{"issue":"7\u20138","key":"1911_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1101\/gad.332494.119","volume":"34","author":"W Zhang","year":"2020","unstructured":"Zhang W, Ma L, Yang M, Shao Q, Xu J, Lu Z, et al. Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly\/autism phenotypes. Genes Dev. 2020;34(7\u20138):580\u201397. https:\/\/doi.org\/10.1101\/gad.332494.119.","journal-title":"Genes Dev"},{"issue":"1\u20132","key":"1911_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/21541248.2016.1277001","volume":"9","author":"ML Mignogna","year":"2018","unstructured":"Mignogna ML, D'Adamo P. Critical importance of RAB proteins for synaptic function. Small GTPases. 2018;9(1\u20132):145\u201357. https:\/\/doi.org\/10.1080\/21541248.2016.1277001.","journal-title":"Small GTPases"},{"key":"1911_CR7","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1038\/ncomms7504","volume":"6","author":"ML Mignogna","year":"2015","unstructured":"Mignogna ML, Giannandrea M, Gurgone A, Fanelli F, Raimondi F, Mapelli L, et al. The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat Commun. 2015;6:6504. https:\/\/doi.org\/10.1038\/ncomms7504.","journal-title":"Nat Commun"},{"issue":"12","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.15252\/embj.201593350","volume":"35","author":"C Sellier","year":"2016","unstructured":"Sellier C, Campanari ML, Julie Corbier C, Gaucherot A, Kolb-Cheynel I, Oulad-Abdelghani M, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35(12):1276\u201397. https:\/\/doi.org\/10.15252\/embj.201593350.","journal-title":"EMBO J"},{"issue":"3","key":"1911_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/humu.22497","volume":"35","author":"L Vanmarsenille","year":"2014","unstructured":"Vanmarsenille L, Giannandrea M, Fieremans N, Verbeeck J, Belet S, Raynaud M, et al. Increased dosage of RAB39B affects neuronal development and could explain the cognitive impairment in male patients with distal Xq28 copy number gains. Hum Mutat. 2014;35(3):377\u201383. https:\/\/doi.org\/10.1002\/humu.22497.","journal-title":"Hum Mutat"},{"key":"1911_CR10","unstructured":"Friedman JM. Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. GeneReviews((R)). Seattle: University of Washington; 1993\u20132020."},{"issue":"1","key":"1911_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1\u20136.","journal-title":"Am J Med Genet"},{"issue":"2","key":"1911_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng.3469","volume":"48","author":"R Rahbari","year":"2016","unstructured":"Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48(2):126\u201333. https:\/\/doi.org\/10.1038\/ng.3469.","journal-title":"Nat Genet"},{"key":"1911_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/genes10080580","volume":"10","author":"T Giugliano","year":"2019","unstructured":"Giugliano T, Santoro C, Torella A, Del Vecchio BF, Grandone A, Onore ME, et al. Clinical and genetic findings in children with Neurofibromatosis type 1, Legius syndrome, and other related Neurocutaneous disorders. Genes. 2019;10:8. https:\/\/doi.org\/10.3390\/genes10080580.","journal-title":"Genes."},{"issue":"3","key":"1911_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ajmg.a.38589","volume":"176","author":"T Giugliano","year":"2018","unstructured":"Giugliano T, Santoro C, Torella A, Del Vecchio BF, Bernardo P, Nigro V, et al. UBE2A deficiency in two siblings: a novel splicing variant inherited from a maternal germline mosaicism. Am J Med Genet A. 2018;176(3):722\u20136. https:\/\/doi.org\/10.1002\/ajmg.a.38589.","journal-title":"Am J Med Genet A"},{"key":"1911_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-015-0045-4","volume":"10","author":"IF Mata","year":"2015","unstructured":"Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Mol Neurodegener. 2015;10:50. https:\/\/doi.org\/10.1186\/s13024-015-0045-4.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1911_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11065-018-9380-x","volume":"28","author":"AK Chisholm","year":"2018","unstructured":"Chisholm AK, Anderson VA, Pride NA, Malarbi S, North KN, Payne JM. Social function and autism Spectrum disorder in children and adults with Neurofibromatosis type 1: a systematic review and meta-analysis. Neuropsychol Rev. 2018;28(3):317\u201340. https:\/\/doi.org\/10.1007\/s11065-018-9380-x.","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","volume":"15","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P, et al. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphan J Rare Dis. 2020;15(1):37. https:\/\/doi.org\/10.1186\/s13023-020-1310-3.","journal-title":"Orphan J Rare Dis"},{"issue":"4","key":"1911_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136(4):349\u201376. https:\/\/doi.org\/10.1007\/s00439-017-1766-y.","journal-title":"Hum Genet"},{"issue":"6","key":"1911_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10803-014-2321-5","volume":"45","author":"S Garg","year":"2015","unstructured":"Garg S, Plasschaert E, Descheemaeker MJ, Huson S, Borghgraef M, Vogels A, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord. 2015;45(6):1649\u201357. https:\/\/doi.org\/10.1007\/s10803-014-2321-5.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"1911_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-018-0477-x","volume":"44","author":"C Santoro","year":"2018","unstructured":"Santoro C, Bernardo P, Coppola A, Pugliese U, Cirillo M, Giugliano T, et al. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough? Ital J Pediatr. 2018;44(1):41. https:\/\/doi.org\/10.1186\/s13052-018-0477-x.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/mp.2014.193","volume":"21","author":"H Hu","year":"2016","unstructured":"Hu H, Haas SA, Chelly J, Van Esch H, Raynaud M, de Brouwer AP, et al. X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. Mol Psychiatry. 2016;21(1):133\u201348. https:\/\/doi.org\/10.1038\/mp.2014.193.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"1911_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/mds.26828","volume":"31","author":"CH Shi","year":"2016","unstructured":"Shi CH, Zhang SY, Yang ZH, Yang J, Shang DD, Mao CY, et al. A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification. Mov Disord. 2016;31(12):1905\u20139. https:\/\/doi.org\/10.1002\/mds.26828.","journal-title":"Mov Disord"},{"key":"1911_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2017.08.021","volume":"44","author":"A Ciammola","year":"2017","unstructured":"Ciammola A, Carrera P, Di Fonzo A, Sassone J, Villa R, Poletti B, et al. X-linked parkinsonism with intellectual disability caused by novel mutations and somatic mosaicism in RAB39B gene. Parkinsonism Relat Disord. 2017;44:142\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.021.","journal-title":"Parkinsonism Relat Disord"},{"issue":"16","key":"1911_CR24","doi-asserted-by":"publisher","first-page":"15485","DOI":"10.1074\/jbc.R500003200","volume":"280","author":"SR Pfeffer","year":"2005","unstructured":"Pfeffer SR. Structural clues to Rab GTPase functional diversity. J Biol Chem. 2005;280(16):15485\u20138. https:\/\/doi.org\/10.1074\/jbc.R500003200.","journal-title":"J Biol Chem"},{"issue":"W1","key":"1911_CR25","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296\u2013303. https:\/\/doi.org\/10.1093\/nar\/gky427.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.str.2013.06.016","volume":"21","author":"AR Khan","year":"2013","unstructured":"Khan AR, Menetrey J. Structural biology of Arf and Rab GTPases' effector recruitment and specificity. Structure. 2013;21(8):1284\u201397. https:\/\/doi.org\/10.1016\/j.str.2013.06.016.","journal-title":"Structure."},{"key":"1911_CR27","doi-asserted-by":"publisher","first-page":"735419","DOI":"10.1155\/2013\/735419","volume":"2013","author":"H Yilmaz","year":"2013","unstructured":"Yilmaz H, Erkin G, Gumus H, Nalbant L. Coexistence of Neurofibromatosis Type-1 and MTHFR C677T gene mutation in a young stroke patient: a case report. Case Rep Neurol Med. 2013;2013:735419. https:\/\/doi.org\/10.1155\/2013\/735419.","journal-title":"Case Rep Neurol Med"},{"issue":"5","key":"1911_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1684\/ejd.2016.2830","volume":"26","author":"X Lin","year":"2016","unstructured":"Lin X, Chen H, Zhu W, Lian S. Neurofibromatosis type 1 and X-linked ichthyosis in a patient with a novel frameshift mutation in the NF1 gene. Eur J Dermatol. 2016;26(5):498\u20139. https:\/\/doi.org\/10.1684\/ejd.2016.2830.","journal-title":"Eur J Dermatol"},{"key":"1911_CR29","doi-asserted-by":"publisher","unstructured":"Altay D, Gorukmez O, Arslan D. Coexistence of three different mutations in a male infant: neurofibromatosis type 1, progressive familial intrahepatic cholestasis type 2 and LPIN3. Fetal Pediatr Pathol. 2020:1\u20136. https:\/\/doi.org\/10.1080\/15513815.2020.1783405.","DOI":"10.1080\/15513815.2020.1783405"},{"issue":"6","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/ajmg.a.32837","volume":"149A","author":"C Thiel","year":"2009","unstructured":"Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, et al. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A. 2009;149A(6):1263\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.32837.","journal-title":"Am J Med Genet A"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01911-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:06:11Z","timestamp":1630454771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01911-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01911-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approved by the Ethics Committee of the University of Campania \u201cLuigi Vanvitelli\u201d. As the legal representative of a minor, proband\u2019s mother gave written informed consent to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the legal representative of a minor, proband\u2019s mother gave written informed consent to the publication and to the photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}